Stockscreener 앱 받기
22.22
2.03%
-0.46
시장 영업 전:
22.22
전일 마감가:
$22.68
열려 있는:
$22.68
하루 거래량:
1.23M
Relative Volume:
1.05
시가총액:
$1.02B
수익:
$203.27M
순이익/손실:
$-4.66M
주가수익비율:
-222.20
EPS:
-0.1
순현금흐름:
$3.47M
1주 성능:
+22.29%
1개월 성능:
+24.55%
6개월 성능:
+36.57%
1년 성능:
+58.71%
1일 변동 폭
$21.68
$22.99
1주일 범위
$17.14
$23.14
52주 변동 폭
$9.215
$23.14
Axogen Inc Stock (AXGN) Company Profile
명칭
Axogen Inc
전화
(386) 462-6817
주소
13631 PROGRESS BLVD., ALACHUA, FL
AXGN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
22.22 | 1.05B | 203.27M | -4.66M | 3.47M | -0.10 |
|
ABT
Abbott Laboratories
|
123.62 | 216.79B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
100.72 | 149.02B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
356.24 | 141.06B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
90.70 | 116.68B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
82.45 | 49.01B | 5.88B | 1.34B | 577.90M | 2.3455 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-17 | 개시 | Lake Street | Buy |
| 2024-07-01 | 개시 | Raymond James | Outperform |
| 2022-11-11 | 재개 | Jefferies | Buy |
| 2022-05-09 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2022-03-11 | 재개 | Cantor Fitzgerald | Overweight |
| 2020-10-23 | 개시 | Guggenheim | Buy |
| 2020-06-16 | 재개 | Cantor Fitzgerald | Overweight |
| 2020-05-07 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2020-04-02 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2019-08-07 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2019-07-12 | 개시 | Canaccord Genuity | Buy |
| 2018-03-02 | 재확인 | Lake Street | Buy |
| 2018-01-05 | 재개 | Cantor Fitzgerald | Overweight |
| 2017-11-30 | 개시 | Jefferies | Buy |
| 2017-11-21 | 재확인 | Lake Street | Buy |
| 2017-07-31 | 개시 | Leerink Partners | Outperform |
| 2017-06-30 | 개시 | Cantor Fitzgerald | Overweight |
| 2017-03-06 | 개시 | ROTH Capital | Buy |
| 2016-11-22 | 업그레이드 | Lake Street | Hold → Buy |
| 2016-11-07 | 재확인 | Wedbush | Outperform |
| 2016-11-03 | 다운그레이드 | Lake Street | Buy → Hold |
| 2016-08-04 | 재확인 | Wedbush | Outperform |
| 2014-05-14 | 개시 | Dawson James | Buy |
| 2013-10-31 | 재확인 | Ladenburg Thalmann | Buy |
모두보기
Axogen Inc 주식(AXGN)의 최신 뉴스
How risky is Axogen Inc. stock nowTrade Signal Summary & Daily Chart Pattern Signal Reports - newser.com
Technical analysis overview for Axogen Inc. stockEarnings Recap Report & Technical Confirmation Trade Alerts - newser.com
HC Wainwright Issues Optimistic Outlook for AxoGen Earnings - MarketBeat
AxoGen FY2025 EPS Estimate Reduced by Cantor Fitzgerald - MarketBeat
Order flow analysis tools used on Axogen Inc.2025 Winners & Losers & Growth Focused Stock Pick Reports - newser.com
Does Axogen Inc. show high probability of reboundWeekly Stock Recap & Low Drawdown Momentum Ideas - newser.com
What drives Axogen Inc stock priceMarket Capitalization Trends & Free Triple Digit Wealth Increase - earlytimes.in
Y Intercept Hong Kong Ltd Makes New Investment in AxoGen, Inc. $AXGN - MarketBeat
AxoGen (NASDAQ:AXGN) Director Sells $826,829.25 in Stock - MarketBeat
Insider Selling: AxoGen (NASDAQ:AXGN) Director Sells 18,248 Shares of Stock - MarketBeat
Why Axogen (AXGN) Is Up 22.3% After Returning to Profitability and Raising 2025 Guidance - simplywall.st
Will Axogen Inc. stock deliver strong dividend growthJuly 2025 Pullbacks & Safe Entry Point Identification - newser.com
Axogen, Inc. Hits New 52-Week High of $22.95, Surges 217.86% - Markets Mojo
Axogen Stock Soars 23% to Intraday High Amid Strong Market Activity - Markets Mojo
Will Axogen Inc. stock gain from government policiesShort Setup & Advanced Technical Analysis Signals - newser.com
Axogen Reports Strong Q3 2025 Results, Raises Guidance - MSN
Axogen Insider Sold Shares Worth $1,246,717, According to a Recent SEC Filing - MarketScreener
Axogen Director William P. Burke Sells Over 58,000 Shares - TradingView
HC Wainwright Increases AxoGen (NASDAQ:AXGN) Price Target to $26.00 - MarketBeat
Axogen raises 2025 revenue growth target to at least 19% as BLA for Avance Nerve Graft nears key milestone - MSN
AxoGen (NASDAQ:AXGN) Stock Price Expected to Rise, Raymond James Financial Analyst Says - MarketBeat
Canaccord Genuity Group Raises AxoGen (NASDAQ:AXGN) Price Target to $27.00 - MarketBeat
3 Stocks Estimated To Be Trading Below Their Fair Value In October 2025 - simplywall.st
What’s next for Axogen Inc. stock pricePortfolio Performance Report & High Return Trade Opportunity Guides - newser.com
What the charts say about Axogen Inc. today2025 Price Momentum & Advanced Technical Signal Analysis - newser.com
Is Axogen Inc. stock attractive after correction2025 Earnings Surprises & Verified Entry Point Signals - newser.com
Is Axogen Inc. stock ready for a breakout2025 Market Overview & Expert Curated Trade Ideas - newser.com
How buybacks impact Axogen Inc. stock valueWeekly Profit Analysis & Stock Portfolio Risk Management - newser.com
Axogen, Inc. (AXGN) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Canaccord Genuity Maintains Axogen (AXGN) Buy Recommendation - Nasdaq
Raymond James Maintains Axogen (AXGN) Outperform Recommendation - Nasdaq
Axogen Inc (AXGN) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Advancements - Investing.com Canada
Axogen (AXGN): Revenue Forecast to Grow 13.8% Annually Heading Into Earnings Season - Yahoo Finance
Axogen (AXGN): HC Wainwright & Co. Raises Price Target to $26 | - GuruFocus
AxoGen stock price target raised to $28 from $22 at Leerink Partners - Investing.com Australia
Axogen Inc (AXGN) Q3 2025 Earnings Call Highlights: Strong Reven - GuruFocus
AxoGen stock price target raised to $28 from $22 at Leerink Partners By Investing.com - Investing.com South Africa
AXGN: Raymond James Raises Price Target for Axogen to $27.00 | A - GuruFocus
AxoGen (NASDAQ:AXGN) Announces Quarterly Earnings Results - MarketBeat
AxoGen (NASDAQ:AXGN) Hits New 1-Year HighShould You Buy? - MarketBeat
AxoGen (AXGN) Q3 Earnings and Revenues Top Estimates - MSN
AxoGen, Inc. (NASDAQ:AXGN) Q3 2025 Earnings Call Transcript - Insider Monkey
Multi factor analysis applied to Axogen Inc.Weekly Trade Analysis & Scalable Portfolio Growth Ideas - newser.com
Is Axogen About To Hit A Clinical Nerve With Avance Approval? - RTTNews
Citizens raises AxoGen stock price target to $34 on differentiated products By Investing.com - Investing.com South Africa
Citizens raises AxoGen stock price target to $34 on differentiated products - Investing.com
Price action breakdown for Axogen Inc.Weekly Risk Summary & Short-Term Swing Trade Alerts - newser.com
AxoGen Q3 2025 Earnings Preview - MSN
Axogen Inc (AXGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.34%
14.63%
자본화:
|
볼륨(24시간):